Suppr超能文献

基因技术的道德判断:德语区人群中基因技术问卷的验证

Moral judgment of genetic technologies: validation of the genetic technologies questionnaire in the German-speaking population.

作者信息

Teichmann Birgit, Melchior Florian, Beyreuther Konrad, Chorianopoulou Maria K

机构信息

Network Aging Research (NAR), Heidelberg University, Heidelberg, Germany.

Department of Philosophy, National and Kapodistrian University of Athens, Athens, Greece.

出版信息

Front Genet. 2025 Aug 1;16:1620962. doi: 10.3389/fgene.2025.1620962. eCollection 2025.

Abstract

INTRODUCTION

The development of modern life sciences has expanded our biomedical capabilities to an unprecedented degree. For example, genetic testing can be used to predict hereditary predisposition or susceptibility to certain diseases. The development of gene scissors such as CRISPR/Cas makes it possible to repair the disease gene or introduce a protective gene in somatic cells but also in germline cells, leading to permanent changes of the genome. But is everything we "can" do morally justifiable? To what extent does the moral status of the living being, autonomy, and privacy influence the decision of whether something is morally "good" or "bad"? There is a lack of valid instruments to study the moral judgment of genetic technologies. Therefore, the aim of this study is to translate and validate the "Genetic Technologies Questionnaire" (GTQ) and the short version of the "Conventional Technologies Questionnaire" (CTQ5) into German.

METHODS

Convenience sampling (N = 317) was used to conduct a cross-sectional online study. Analyses included internal consistency, structural validity, known group construct validity, tests for floor and ceiling effects, and retest reliability with a subset of n = 69. Correlational analyses were conducted with education, age, prior knowledge of genetics, religiosity, conventional technologies, and prior genetic testing. This study used the STROBE checklist for reporting.

RESULTS

The GTQ30 (Cronbach's α = 0.938) and GTQ20 (α = 0.940) are reliable and stable instruments for testing the moral judgment of lay people, while the GTQ5 (α = 0.857) and CTQ5 (α = 0.697) showed some weaknesses. Conventional technologies were judged morally better than genetic technologies, and genetic testing considered better than genome editing. Two additional versions were validated: the GTQ-Human (GTQ-H), using all items relating to humans, and the GTQ-Moral Status (GTQ-MS), including one item per different group of living beings for genetic testing and one for genome editing.

CONCLUSION

The GTQ is a valid instrument that is now available in shorter versions for different areas of research: the GTQ-MS for philosophical questions addressing moral status and the GTQ-H for biomedical and psychological questions related to research, prognosis, diagnosis, and therapy in humans.

摘要

引言

现代生命科学的发展将我们的生物医学能力提升到了前所未有的高度。例如,基因检测可用于预测遗传易感性或对某些疾病的易感性。诸如CRISPR/Cas等基因剪刀的发展使得修复疾病基因或在体细胞甚至生殖细胞中引入保护基因成为可能,从而导致基因组的永久性改变。但我们“能”做的一切在道德上都合理吗?生物的道德地位、自主性和隐私在何种程度上会影响某件事在道德上是“好”还是“坏”的判断?目前缺乏研究基因技术道德判断的有效工具。因此,本研究的目的是将“基因技术问卷”(GTQ)和“传统技术问卷简版”(CTQ5)翻译成德语并进行验证。

方法

采用便利抽样(N = 317)进行横断面在线研究。分析包括内部一致性、结构效度、已知群体建构效度、地板效应和天花板效应检验,以及对n = 69的子集进行重测信度分析。对教育程度、年龄、遗传学先验知识、宗教信仰、传统技术和先前的基因检测进行了相关性分析。本研究使用STROBE清单进行报告。

结果

GTQ30(克朗巴哈α系数 = 0.938)和GTQ-20(α = 0.940)是用于测试外行人道德判断的可靠且稳定的工具,而GTQ5(α = 0.857)和CTQ5(α = 0.697)存在一些弱点。人们认为传统技术在道德上优于基因技术,基因检测比基因组编辑更好。还验证了另外两个版本:GTQ-人类版(GTQ-H),使用所有与人类相关的项目;以及GTQ-道德地位版(GTQ-MS),包括针对基因检测的不同生物群体各一项以及针对基因组编辑的一项。

结论

GTQ是一种有效的工具,现在有不同研究领域的简短版本:GTQ-MS用于解决道德地位的哲学问题,GTQ-H用于与人类研究、预后、诊断和治疗相关的生物医学和心理学问题。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验